A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B
Clinical trial NCT05717686 · COMPLETED
Trial details
- NCT number
- NCT05717686
- Sponsor
- AusperBio Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2025-01-07
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.